Abstract
Proton-pump inhibitor (PPI) use is believed to increase the risk for Clostridium difficile infection (CDI), presumably by altering the bacteria normally found in the gut. To further investigate this presumption, researchers conducted a prospective, open-label trial involving 12 healthy volunteers. Stool samples were obtained at baseline and 4 weeks, after which all participants …
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
